X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK vs ALEMBIC PHARMA - Comparison Results

MERCK    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK ALEMBIC PHARMA MERCK/
ALEMBIC PHARMA
 
P/E (TTM) x 57.0 17.9 318.7% View Chart
P/BV x 8.6 4.5 188.7% View Chart
Dividend Yield % 0.4 0.7 53.0%  

Financials

 MERCK   ALEMBIC PHARMA
EQUITY SHARE DATA
    MERCK
Dec-17
ALEMBIC PHARMA
Mar-18
MERCK/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs1,358645 210.4%   
Low Rs933470 198.6%   
Sales per share (Unadj.) Rs665.0166.1 400.4%  
Earnings per share (Unadj.) Rs56.621.9 258.3%  
Cash flow per share (Unadj.) Rs72.527.5 263.6%  
Dividends per share (Unadj.) Rs15.004.00 375.0%  
Dividend yield (eoy) %1.30.7 182.5%  
Book value per share (Unadj.) Rs441.7117.8 375.1%  
Shares outstanding (eoy) m16.60188.52 8.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.73.4 51.3%   
Avg P/E ratio x20.225.5 79.5%  
P/CF ratio (eoy) x15.820.3 77.9%  
Price / Book Value ratio x2.64.7 54.8%  
Dividend payout %26.518.3 145.2%   
Avg Mkt Cap Rs m19,011105,090 18.1%   
No. of employees `0001.5NA-   
Total wages/salary Rs m1,6966,228 27.2%   
Avg. sales/employee Rs Th7,150.0NM-  
Avg. wages/employee Rs Th1,098.7NM-  
Avg. net profit/employee Rs Th608.2NM-  
INCOME DATA
Net Sales Rs m11,04031,308 35.3%  
Other income Rs m24070 341.0%   
Total revenues Rs m11,27931,378 35.9%   
Gross profit Rs m1,3766,431 21.4%  
Depreciation Rs m2641,055 25.0%   
Interest Rs m034 0.0%   
Profit before tax Rs m1,3525,413 25.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-81 0.0%   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m5831,204 48.4%   
Profit after tax Rs m9394,128 22.7%  
Gross profit margin %12.520.5 60.7%  
Effective tax rate %43.122.2 193.9%   
Net profit margin %8.513.2 64.5%  
BALANCE SHEET DATA
Current assets Rs m7,52318,247 41.2%   
Current liabilities Rs m2,25311,235 20.1%   
Net working cap to sales %47.722.4 213.2%  
Current ratio x3.31.6 205.6%  
Inventory Days Days5286 61.0%  
Debtors Days Days4161 66.1%  
Net fixed assets Rs m1,24020,035 6.2%   
Share capital Rs m166377 44.0%   
"Free" reserves Rs m7,16721,824 32.8%   
Net worth Rs m7,33322,201 33.0%   
Long term debt Rs m05,000 0.0%   
Total assets Rs m9,91239,411 25.2%  
Interest coverage xNM160.2-  
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x1.10.8 140.2%   
Return on assets %9.510.6 89.7%  
Return on equity %12.818.6 68.9%  
Return on capital %20.819.7 105.2%  
Exports to sales %046.4 0.0%   
Imports to sales %010.5 0.0%   
Exports (fob) Rs mNA14,535 0.0%   
Imports (cif) Rs mNA3,288 0.0%   
Fx inflow Rs m1,01514,722 6.9%   
Fx outflow Rs m3,0437,026 43.3%   
Net fx Rs m-2,0287,696 -26.4%   
CASH FLOW
From Operations Rs m5373,124 17.2%  
From Investments Rs m-476-8,844 5.4%  
From Financial Activity Rs m-2205,026 -4.4%  
Net Cashflow Rs m-160-693 23.0%  

Share Holding

Indian Promoters % 0.0 74.1 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 2.9 627.6%  
FIIs % 1.0 9.1 11.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 13.9 209.4%  
Shareholders   28,591 49,328 58.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK With:   UNICHEM LAB  VENUS REMEDIES  IPCA LABS  GLENMARK PHARMA  AUROBINDO PHARMA  

Compare MERCK With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex at New Highs, Jet Airways Suspends Operations - Your Inside Scoop of the Markets(Podcast)

Jet Airways, once India's largest private airline halted its operations indefinitely yesterday. The carrier flew its last scheduled flight from Amritsar to Mumbai yesterday.

Related Views on News

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 11 bn (up 42.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

MERCK SHARE PRICE


Apr 18, 2019 (Close)

TRACK MERCK

COMPARE MERCK WITH

MARKET STATS